Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the Government has undertaken an assessment of which immunocompromised patients should be eligible for treatment with the drug, Evusheld, due to their lack of response to the covid-19 vaccine; and whether the Government has plans to undertake antibody testing on those individuals to assess their response.

The Department is reviewing the potential introduction of pre-exposure prophylaxis treatments, such as Evusheld. This includes the identification of appropriate patient groups, the potential deployment and administration process and assessment of antibody testing prior to treatment.